Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
35.38
+0.15 (0.43%)
At close: Feb 12, 2026
Market Cap4.71B +4.6%
Revenue (ttm)430.96M -40.2%
Net Income133.44M -59.8%
EPS0.97 -60.0%
Shares Out134.87M
PE Ratio35.87
Forward PE27.74
Dividend0.56 (1.60%)
Ex-Dividend Daten/a
Volume2,542,319
Average Volume2,061,406
Open35.15
Previous Close35.23
Day's Range34.65 - 36.29
52-Week Range27.56 - 40.00
Beta1.01
RSI51.60
Earnings DateApr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 558
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2024, SHA:688253's revenue was 621.39 million, an increase of 29.99% compared to the previous year's 478.02 million. Earnings were 246.86 million, an increase of 41.92%.

Financial Statements